ACD Gene Dyskeratosis Congenita, Autosomal Recessive Type 7 (DKC7) Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

Guaranteed 99.9% diagnostic sensitivity via ISO 15189‑aligned NGS, delivered with complete UAE regulatory adherence.

Premium Logistics: Hospital‑Grade Home Collection (8 AM‑11 PM) via ISO Certified Cold‑Chain Transport and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Interpretation by a DHA‑licensed genetic counsellor.
Price: 2,800 AED
Turnaround Time: 3–4 Weeks

Test Overview & Methodology

Next‑Generation Sequencing (NGS) of the entire ACD gene detects pathogenic variants responsible for Dyskeratosis Congenita type 7, a telomere biology disorder presenting with skin hyperpigmentation, nail dystrophy, oral leukoplakia, and bone marrow failure. Early genetic diagnosis guides multidisciplinary surveillance for cancer predisposition and pulmonary complications.

Feature	This Test (Precision Genomics)	Closest Alternative
Methodology	NGS – full gene sequencing + copy number analysis	Sanger sequencing (single‑exon only)
Turnaround Time	3–4 Weeks	6–8 Weeks
Diagnostic Yield	>99% for pathogenic SNVs & CNVs	~85% (misses deep intronic variants)

Physician Insight & Safety Protocols

“A positive ACD result must be interpreted within the full clinical context; I always combine this with telomere length measurement and family history before diagnosing Dyskeratosis Congenita. This test is a cornerstone for tailored surveillance, but it does not replace a thorough dermatology and hematology evaluation.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA 9294403)

Medication Advisory

Do not discontinue any prescribed medication or modify androgen/danazol therapy without consulting your specialist. Abrupt withdrawal may precipitate bone marrow failure.

Safety Exclusion Criteria & ER Red Flags

Active severe pancytopenia (Hb <8 g/dL, ANC <0.5×10⁹/L) – seek immediate hematology assessment.
Progressive pulmonary fibrosis symptoms (dyspnea at rest) – avoid home collection; go to emergency.
Age below 18 without legal guardian consent – test cannot proceed.

Patient FAQ & Clinical Guidance

1. What exactly does the ACD gene test detect?

This test identifies single nucleotide variants and large rearrangements in the ACD gene that cause dyskeratosis congenita type 7, a disorder marked by bone marrow failure and cancer predisposition.

2. How will my blood sample be collected safely at home?

A DHA‑licensed pediatric/adult phlebotomist arrives with an ISO‑certified cold‑chain kit, performs a simple venipuncture, and immediately stabilizes the sample for transport to the genomics lab.

3. Is genetic counselling mandatory before this test?

Yes, UAE regulations mandate a pre‑counselling session to draw a detailed pedigree chart and ensure fully informed consent before any genetic analysis.

UAE Regulatory & Data Privacy Adherence

Data Privacy: All personal data is processed in compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Medical Liability: Clinical testing and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Accreditation: ISO 15189:2022 accredited laboratory (DHA Facility License No. 1143). Corporate Lab: DNA Labs UAE.

Clinical & Logistical Metadata

Test Name	ACD Gene Dyskeratosis Congenita, Autosomal Recessive Type 7 (DKC7) Genetic Test
Price (AED)	2,800 AED
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Peripheral Whole Blood – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM)
Methodology Used	Next‑Generation Sequencing (NGS) – Full gene sequencing plus copy number variant (CNV) analysis
ICD-10-CM Code	Q82.8 (Dyskeratosis Congenita), D61.09 (Constitutional Aplastic Anemia), Z15.89 (Genetic Susceptibility to Other Disease)
LOINC Code	102578-5 (Full ACD gene sequencing)
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab: DNA Labs UAE